Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein
about
Role of EBNA-3 Family Proteins in EBV Associated B-cell LymphomagenesisThe EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growthInduction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexusA Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic virusesStabilization of Myc through heterotypic poly-ubiquitination by mLANA is critical for γ-herpesvirus lymphoproliferation.EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferationEBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases.Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Autoimmune diseases and polyamines.Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis.Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability.Epigenetic alterations and autoimmune disease.The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival.Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas.
P2860
Q26752541-7F504394-E11D-4A83-8C61-5081DA8BB2E6Q28546003-4E776E70-16F3-427F-AA19-74C6CE5DB62DQ31111648-66EB35B3-A9D4-4F84-9EF1-7E439AF10FEFQ33604848-04B2286B-87DB-449A-898F-D9DD5E0C0FDEQ33828576-BB325F8F-6A5F-45CC-99AA-7617863535F0Q34043443-6261B1E9-7C60-4711-A932-23B4F62FD8BBQ34047060-B4028895-47B5-4CE2-8824-32442111D364Q34097970-719FEC38-7AF7-4BF0-9AEA-BDEF81FD97AFQ34102722-5D6C4CB7-97CE-47A4-8FE7-C6E0A9E31BB4Q34115503-0FD24A7B-F2CC-4526-B98D-36F95FD65A27Q34205875-BA8499B3-F357-4E5E-B90D-A3B37B99F06BQ34711793-4736CF61-0818-445C-AD6E-A6CC60F1FA66Q34741776-E349CC3D-5043-4C76-9CDC-4C1CE17ACB7BQ34872837-B2BC0CA9-6D2F-4901-B5A5-40888494B79FQ34901718-3EEFF7D8-20EC-4B0F-8EEB-F429AC8B1AFCQ34945490-AD17707C-F008-4B52-BB17-D623FA0B93AAQ35224422-E102BBA4-273F-4933-834A-14F91FD815CDQ36109083-CBFB182F-1115-4620-8057-35B16922D5FFQ36770840-822CCDDD-BB10-4C6E-A2BE-CDE923D615FDQ37132783-EFF824DB-908B-4D09-B6B3-C1AFD96FE094Q37452130-7CBD0A70-A9B8-4AA0-8F3D-9909B4FCF9E3Q37849461-1F91AD1B-1341-4313-B610-3C3F08353BEDQ37960864-E3451186-EA25-4926-829B-E6685505B3D4Q38086861-0AEE4BDA-715A-40E8-BA9B-F0704ECD18C3Q38286347-D3D07966-D4DD-491B-9509-23726095D4AEQ38337443-7D3A6F73-55B9-4618-B818-E940D110DD0EQ38664787-F043FDC5-4196-454B-9DBB-4B331339236DQ38854742-9ED95150-8E05-42D0-81A8-883C9938420AQ39329214-6BE44F1A-7C90-4A24-9326-A0DFD31A8110Q39879529-2BF0F0FB-F0C3-4393-87B1-ED7583A28CA6Q41112559-03773E88-5EA6-48EE-B474-4F459B13C726Q41900816-3E58189B-B159-445D-9ED7-51E2CE350FB2Q43522609-A8325F65-2BBF-4854-8CEE-A117B02BD811Q54251658-9741E95C-A57A-448D-B8F2-C2A86796AE31Q54978478-00E83651-8EF1-47A2-BD84-7C942BAD74DCQ55272984-CE01C623-B97F-49ED-B425-A8FD6841FFCF
P2860
Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@ast
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en-gb
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@nl
type
label
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@ast
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en-gb
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@nl
prefLabel
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@ast
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en-gb
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@nl
P2093
P2860
P3181
P356
P1433
P1476
Epstein-Barr virus nuclear ant ...... ility of the c-Myc oncoprotein
@en
P2093
Bharat G Bajaj
Masanao Murakami
Qiliang Cai
P2860
P304
P3181
P356
10.1128/JVI.02500-07
P407
P577
2008-04-01T00:00:00Z